These findings reveal the competence of linagliptin to suppress DPP-4 and enhance SDF-1α protein without affecting the uptake of cadmium to the testes of cadmium-intoxicated rats or provoking hypoglycemia. The gene discussed is CXCL12; the disease is Hypoglycemia.